Gadeta Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Gadeta General Information

Description

Developer of innovative immunotherapies designed to treat cancer. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell receptors (TCRs) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, thereby enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors lowering the chances of cancer.

Contact Information

Website
www.gadeta.nl
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 085
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Clade Therapeutics
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Yalelaan 62
  • 3584 CM Utrecht
  • Netherlands
+31 085

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gadeta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 02-Oct-2023 Completed Clinical Trials - General
4. Early Stage VC 19-Jul-2018 Completed Clinical Trials - General
3. Early Stage VC (Series A) 29-Mar-2016 Completed Startup
2. Seed Round Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Gadeta’s complete valuation and funding history, request access »

Gadeta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of innovative immunotherapies designed to treat cancer. The company's innovative immunotherapies are based on
Biotechnology
Utrecht, Netherlands
31 As of 2023

Palo Alto, CA
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gadeta Competitors (104)

One of Gadeta’s 104 competitors is MaveriX Oncology, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MaveriX Oncology Venture Capital-Backed Palo Alto, CA
NexImmune Formerly VC-backed Gaithersburg, MD
Tizona Therapeutics Venture Capital-Backed San Francisco, CA
CalciMedica Formerly VC-backed La Jolla, CA
TScan Therapeutics Formerly VC-backed Waltham, MA
You’re viewing 5 of 104 competitors. Get the full list »

Gadeta Patents

  • 49

    Total Documents Applications and Grants

  • Total Patents Families

  • 33

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Gadeta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240043496-A1 Delta t-cell or gamma receptor chains or parts thereof for treating ovarian cancer Pending 26-Jul-2022
US-20240075068-A1 Novel soluble gamma t-cell (or soluble delta t-cell) receptor chains (or soluble gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response Pending 15-Jul-2022
EP-4352089-A1 Delta t-cell or gamma t-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response Pending 07-Jun-2021
CA-3203016-A1 Chimeric, transmembrane proteins with bidirectional signalling activity Pending 23-Dec-2020
AU-2021405062-A1 Chimeric, transmembrane proteins with bidirectional signalling activity Pending 23-Dec-2020 A61K40/11
To view Gadeta’s complete patent history, request access »

Gadeta Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gadeta Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Baxalta Ventures Corporate Venture Capital Minority
Index Ventures Venture Capital Minority
Kite Pharma Corporation Majority
Medicxi Venture Capital Minority
Utrecht Holdings Not-For-Profit Venture Capital Minority
To view Gadeta’s complete investors history, request access »

Ready to get started?

Request a free trial

Gadeta FAQs

  • When was Gadeta founded?

    Gadeta was founded in 2015.

  • Where is Gadeta headquartered?

    Gadeta is headquartered in Utrecht, Netherlands.

  • What is the size of Gadeta?

    Gadeta has 31 total employees.

  • What industry is Gadeta in?

    Gadeta’s primary industry is Biotechnology.

  • Is Gadeta a private or public company?

    Gadeta is a Private company.

  • What is Gadeta’s current revenue?

    The current revenue for Gadeta is .

  • How much funding has Gadeta raised over time?

    Gadeta has raised $7.78M.

  • Who are Gadeta’s investors?

    Baxalta Ventures, Index Ventures, Kite Pharma, Medicxi, and Utrecht Holdings have invested in Gadeta.

  • Who are Gadeta’s competitors?

    MaveriX Oncology, NexImmune, Tizona Therapeutics, CalciMedica, and TScan Therapeutics are some of the 104 competitors of Gadeta.

  • When was Gadeta acquired?

    Gadeta was acquired on 02-Oct-2023.

  • Who acquired Gadeta?

    Gadeta was acquired by Clade Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »